X4 Pharmaceuticals, Inc. | ||||
NCM : XFOR || Location: United States | ||||
$1.39-0.02 (-1.42%) |
4.34 M | 1.3 - 1.43 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 14.223 M |
Feb. 29, 2024 | 14.396 M |
Feb. 15, 2024 | 13.232 M |
Jan. 31, 2024 | 12.796 M |
Jan. 12, 2024 | 11.993 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.16 | -0.10 | 35.86% |
09/30/2023 | -0.15 | -0.01 | 93.42% |
06/30/2023 | -0.17 | -0.33 | -98.08% |
03/31/2023 | -0.22 | -0.16 | 27.77% |
12/31/2022 | -0.25 | -0.29 | -17.84% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 167.938M | Shares Float | 130.197M |
Short Float | 14.223M | Market Cap | 233.43M |
Institution ownership | 61.37% | Insider ownership | 0.832% |
Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
Trailing EPS | -0.57 | Forward EPS | -0.44 |